Spinal Cord Injury Focus Study 2022: Data Collection and Evaluation
Join the Spinal Cord Injury Focus Study to collect data on veterans with SCI, focusing on key measures. No DAC or exit conferences; data used to evaluate performance metrics. Learn more about the study's purpose, timeframe, and instrument questions.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
The healthcare improvement experts. SPINAL CORD INJURY FOCUS STUDY VHA EPRP FY2022 Training Jennifer Hall, RN-BSN EPRP Technical Coordinator
Spinal Cord Injury Focus Study Purpose: To collect data on Veterans with a diagnosis of Spinal Cord Injury (SCI) focusing on nine previously retired measures P7s: Tobacco Screened for Use P19s: Immunization - Influenza P24s: Pneumococcal Immunization Refused Pvc12s: Pneumococcal Immunization Scid5: DM Retinal Exam, timely by disease Smg8s: Tobacco Patients using tobacco daily or some days advised to quit Smg9s: Tobacco Patients using tobacco daily or some days offered cessation strategies Smg10s: Tobacco Patients using tobacco daily or some days offered medications Smg19s: Tobacco Use Current User
SCI Focus Study Study Timeframe: 06/01/2021 to 06/30/2022 There will be no Data Accountability Checklist (DAC) or Exit conferences for this focus study Data captured will be used by API-PM to evaluate the performance data for the previously retired CGPI measures
Instrument Questions and Rules The questions and definition/decision rules for this focus study should be familiar as they mirror existing questions from the CGPI instrument One question may be new if you have not previously reviewed CGPI cases that included SCI cohorts Question 2: DXEXCLD
Question: DXEXCLD Question 2 (DXEXCLD) asks: Does the patient have one of the following diagnoses? 1. Multiple Sclerosis (MS), without primary problem of paraplegia 2. Amyotrophic Lateral Sclerosis (ALS) 3. Guillain-Barre Syndrome 4. Malignant tumor of the spinal cord 99. None of the above Excluded: MS in which patient does not have primary problem of paraplegia, ALS (commonly known as Lou Gehrig s disease), Guillain-Barre Syndrome, and malignant tumor of the spinal cord Included: Benign tumors of the spinal cord, MS in which patient does have primary problem of paraplegia (paralysis of the legs and lower part of the body) associated with the disease process.
Question DXEXCLD continued Look carefully on the problem list and progress notes for documentation of any of the four diagnoses listed in the question If you are unsure if a diagnosis is acceptable to answer 1 through 4, check with your RM for guidance If the answer to DXEXCLD is 1, 2, 3, or 4 the case will be excluded from review Exclusion Statement: The patient s diagnosis does not meet inclusion criteria for the spinal cord injury and disorders cohort
Next Steps and Questions The pull list has been received and will be processed and released by 08/01/2022 Abstraction can begin once you have completed this education and notified your Regional Manager The date to complete abstraction is 08/31/2022 If you have questions as you are reviewing, please contact Jennifer Hall: jhall@qualityinsights.org OR your Regional Manager
Thank you for your participation in this training session and focus study!
